Identification of a 17β-Hydroxysteroid Dehydrogenase Type 10 Steroidal Inhibitor: A Tool to Investigate the Role of Type 10 in Alzheimer’s Disease and Prostate Cancer
Version of Record online: 6 JUN 2012
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Volume 7, Issue 7, pages 1181–1184, July 2012
How to Cite
Ayan, D., Maltais, R. and Poirier, D. (2012), Identification of a 17β-Hydroxysteroid Dehydrogenase Type 10 Steroidal Inhibitor: A Tool to Investigate the Role of Type 10 in Alzheimer’s Disease and Prostate Cancer. ChemMedChem, 7: 1181–1184. doi: 10.1002/cmdc.201200129
- Issue online: 25 JUN 2012
- Version of Record online: 6 JUN 2012
- Manuscript Received: 8 MAR 2012
- Canadian Institutes of Health Research (CIHR)
Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.